M Berger - Concepedia

Author

M Berger

Research Institute of Molecular Pathology

Also Known As

M BERGER, M Berger, M. Berger, Manfred Berger

Publications

578

Citations

H-Index

Concepts

All Affiliations

Research Institute of Molecular Pathology

About

M Berger is an author at Research Institute of Molecular Pathology specializing in immunology, medicine, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	547
2	Immunology	8	8	547
3	Cell Biology	4	4	268
4	Allergy	3	3	241
5	Cellular Therapies	1	1	72

M Berger

Publications

563

Citations

H-Index

Page 1

	Year	Citations
Cancer vaccines: the interleukin 2 dosage effect. Wolfgang Schmidt, Tamás Schweighoffer, E Herbst, Proceedings of the National Academy of Sciences ImmunologyImmunologic MechanismProtection EfficiencyImmunotherapyDosage Effect	1995	127
Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination. Gerd Maass, Wolfgang Schmidt, M Berger, Proceedings of the National Academy of Sciences ImmunologyImmunologic MechanismImmunotherapyTumor-specific T CellsTumor Immunology	1995	95
Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters. Kurt Zatloukal, Achim Schneeberger, M Berger, The Journal of Immunology ImmunologyImmunoeditingIl-2 Gene ConstructImmunologic MechanismImmune Cell Therapy	1995	88
In vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery. Kurt Zatloukal, Matthew Cotten, M Berger, Proceedings of the National Academy of Sciences Cell TherapyIn Vivo Gene TherapyImmunologyBlood CellPathology	1994	72
Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Kenneth W. Culver, William Osborne, A. Dusty Miller, PubMed Primary ImmunodeficiencyAllergyHuman THuman RetrovirusImmunology	1991	64
Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens. Frank Mattner, Julia-Kristina Fleitmann, Karen Lingnau, PubMed Long-lasting T-cell ResponsesCancer AntigensImmunologyImmunodominancePeptide Vaccines	2002	50
Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: A new perspective for vaccine development Timm Fiebig, Francesco Berti, Friedrich Freiberger, Glycobiology Purified CpsImmunologyCapsule PolymeraseReverse VaccinologyVaccine Target	2013	38
Composition of the ANTIGENome of Helicobacter pylori defined by human serum antibodies Andreas Meinke, Martin Storm, Tamás Henics, Vaccine Human Serum AntibodiesHelicobacter PyloriMicrobiology	2009	16
Generation of effective cancer vaccines genetically engineered to secrete cytokines using adenovirus-enhanced transferrinfection (AVET) Walter Schmidt, Gerhard Maass, Michael Buschle, Gene VaccinationAdenovirus-enhanced TransferrinfectionEffective Cancer VaccinesImmunologyTherapeutic Vaccine	1997	13

Page 1